Dysregulated ADA activity leads to cardiovascular pathologies such as atherosclerosis, thrombosis, and myocardial ischemia-reperfusion injury (Kutryb-Zajac et al., 2020), suggesting that ADA may be a critical target for treatment of cardiovascular disease. The gene discussed is ADA; the disease is myocardial ischemia.